Clinical Trial Update: Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous stem cell therapy for inflammatory-dystrophic corneal diseases, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Disease
• Corneal Dystrophy
• Corneal Ulcer

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Corneal Ulcer, Corneal Disease | Phase 1, Phase 2 | Status: COMPLETED